Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2008 11
2009 5
2010 11
2011 10
2012 16
2013 38
2014 57
2015 56
2016 76
2017 91
2018 119
2019 110
2020 138
2021 138
2022 140
2023 121
2024 146
2025 157
2026 94

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,304 results

Results by year

Filters applied: . Clear all
Page 1
Chronic Spontaneous Urticaria: A Review.
Kolkhir P, Bonnekoh H, Metz M, Maurer M. Kolkhir P, et al. JAMA. 2024 Nov 5;332(17):1464-1477. doi: 10.1001/jama.2024.15568. JAMA. 2024. PMID: 39325444 Review.
However, at least 30% of patients have an insufficient response to omalizumab, especially those with IgG-mediated autoimmune urticaria. Cyclosporine, used off-label, can improve symptoms in approximately 54% to 73% of patients, especially those with autoimmune ch …
However, at least 30% of patients have an insufficient response to omalizumab, especially those with IgG-mediated autoimmune urtic …
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence.
Metz M, Vadasz Z, Kocatürk E, Giménez-Arnau AM. Metz M, et al. Clin Rev Allergy Immunol. 2020 Aug;59(1):38-45. doi: 10.1007/s12016-020-08794-6. Clin Rev Allergy Immunol. 2020. PMID: 32418171 Free PMC article. Review.
Chronic spontaneous urticaria (CSU) is defined as the spontaneous development of itchy hives and/or angioedema due to known or unknown causes that last for at least 6 weeks. ...Published observational studies (from June 2003 to October 2019) on the updosing of om …
Chronic spontaneous urticaria (CSU) is defined as the spontaneous development of itchy hives and/or angioedema due to known or …
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials.
Maurer M, Casale TB, Saini SS, Ben-Shoshan M, Giménez-Arnau AM, Bernstein JA, Yagami A, Stjepanovic A, Radin A, Staudinger HW, Patel N, Amin N, Akinlade B, Fan C, Bauer D, Yancopoulos GD, Patel K, Mannent LP, Laws E. Maurer M, et al. J Allergy Clin Immunol. 2024 Jul;154(1):184-194. doi: 10.1016/j.jaci.2024.01.028. Epub 2024 Feb 29. J Allergy Clin Immunol. 2024. PMID: 38431226 Free article. Clinical Trial.
BACKGROUND: Chronic spontaneous urticaria (CSU) is a chronic inflammatory disease characterized by recurrent pruritic wheals (hives) and/or angioedema. ...Pooled safety data were consistent between dupilumab and placebo and with the known dupilumab safety pro …
BACKGROUND: Chronic spontaneous urticaria (CSU) is a chronic inflammatory disease characterized by recurrent pruritic w …
Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment.
Zuberbier T, Ensina LF, Giménez-Arnau A, Grattan C, Kocatürk E, Kulthanan K, Kolkhir P, Maurer M. Zuberbier T, et al. Lancet. 2024 Jul 27;404(10450):393-404. doi: 10.1016/S0140-6736(24)00852-3. Epub 2024 Jul 11. Lancet. 2024. PMID: 39004090 Free article. Review.
Chronic urticaria is a common and debilitating mast cell-driven skin disease presenting with itchy wheals, angio-oedema, or both. Chronic urticaria is classified as spontaneous (without definite triggers) and inducible (with definite and subtype-specif …
Chronic urticaria is a common and debilitating mast cell-driven skin disease presenting with itchy wheals, angio-oedema, or bo …
Cost-effective omalizumab dosage for chronic urticaria: a systematic review and network meta-analysis.
Tajerian A, Pourvali A, Khoshkhui M, Movahedi Aliabadi M, Mobinikhaledi M, Faridzadeh A. Tajerian A, et al. Arch Dermatol Res. 2024 Dec 14;317(1):131. doi: 10.1007/s00403-024-03629-2. Arch Dermatol Res. 2024. PMID: 39673624
Chronic urticaria is a persistent skin condition characterized by recurrent wheals (hives) and/or angioedema lasting more than six weeks, significantly impacting quality of life and often requiring long-term management. ...Studies assessing Omalizumab's …
Chronic urticaria is a persistent skin condition characterized by recurrent wheals (hives) and/or angioedema lasting more than …
New insights into chronic inducible urticaria.
Muñoz M, Kiefer LA, Pereira MP, Bizjak M, Maurer M. Muñoz M, et al. Curr Allergy Asthma Rep. 2024 Aug;24(8):457-469. doi: 10.1007/s11882-024-01160-y. Epub 2024 Jul 19. Curr Allergy Asthma Rep. 2024. PMID: 39028396 Free PMC article. Review.
PURPOSE OF REVIEW: Chronic inducible urticaria (CIndU) is a group of long-persisting and challenging to manage diseases, characterized by recurrent wheals and angioedema induced by definite triggers. ...Promising emerging therapies currently assessed in chronic …
PURPOSE OF REVIEW: Chronic inducible urticaria (CIndU) is a group of long-persisting and challenging to manage diseases, chara …
Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances.
Kaplan A, Lebwohl M, Giménez-Arnau AM, Hide M, Armstrong AW, Maurer M. Kaplan A, et al. Allergy. 2023 Feb;78(2):389-401. doi: 10.1111/all.15603. Epub 2022 Dec 7. Allergy. 2023. PMID: 36448493 Review.
Chronic spontaneous urticaria (CSU) is a debilitating skin disease characterized by intensely itchy wheals, angioedema, or both. ...These insights informed the development of therapies such as omalizumab, dupilumab, and Bruton's tyrosine kinase (BTK) inhibito …
Chronic spontaneous urticaria (CSU) is a debilitating skin disease characterized by intensely itchy wheals, angioedema, or bot …
Omalizumab in chronic urticaria.
Metz M, Maurer M. Metz M, et al. Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):406-11. doi: 10.1097/ACI.0b013e328355365a. Curr Opin Allergy Clin Immunol. 2012. PMID: 22766620 Review.
PURPOSE OF REVIEW: The current EAACI/GA2LEN/EDF/WAO treatment guidelines for the management of urticaria recommend omalizumab as fourth-line therapy. Within the last year, many reports of omalizumab treatment in chronic urticaria have been publi …
PURPOSE OF REVIEW: The current EAACI/GA2LEN/EDF/WAO treatment guidelines for the management of urticaria recommend omalizumab …
Management of chronic urticaria: Treatment options when omalizumab fails.
Lang DM. Lang DM. Allergy Asthma Proc. 2025 Sep 1;46(6):455-461. doi: 10.2500/aap.2025.46.250072. Allergy Asthma Proc. 2025. PMID: 41152678 Review.
Therapeutic options for chronic urticaria, particularly for patients who are antihistamine-resistant, have also improved. ...The armamentarium for management of patients with refractory chronic urticaria has recently expanded, and will soon expand furt …
Therapeutic options for chronic urticaria, particularly for patients who are antihistamine-resistant, have also improved. ...T …
Omalizumab in pediatric chronic spontaneous urticaria: A systematic review and meta-analysis of efficacy and safety.
Alomari O, Ozceker D, Mokresh ME, Topçak AB, Ertan SN, Şahin MK, Çalışkan N, Karadag SIK, Erbay MF, Yıldırım G, Bologur H, Güngör H, Kaplan O, Tunç HS, Kocatürk E. Alomari O, et al. Pediatr Allergy Immunol. 2025 Jun;36(6):e70132. doi: 10.1111/pai.70132. Pediatr Allergy Immunol. 2025. PMID: 40545961
Chronic spontaneous urticaria significantly impairs quality of life in children, with limited treatment options beyond antihistamines. ...This systematic review and meta-analysis aim to evaluate the efficacy and safety of omalizumab in pediatric chronic …
Chronic spontaneous urticaria significantly impairs quality of life in children, with limited treatment options beyond antihis …
1,304 results